Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

60%

Ph phase_3

20%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

3(60.0%)

Phase 3Large-scale testing

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (60.0%)

Phase 31 (20.0%)

Phase 41 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_2

Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals

NCT00249509

completedphase_3

Clinical Trials (5)

Showing 5 of 5 trials

NCT00249509Phase 2

Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals

Completed

NCT00000293Phase 3

Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10

Completed

NCT00000286Phase 2

Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3

Completed

NCT00015210Phase 2

Nefazodone in the Treatment of Cocaine Dependence and Depression - 4

Completed

NCT00231348Phase 4

Nefazodone in the Treatment of Social Phobia

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5